myristic acid has been researched along with ciprofloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhake, A; Mourya, V; Narasimhan, B | 1 |
| Binesh, A; Devaraj Sivasitambaram, N; Halagowder, D | 1 |
2 other study(ies) available for myristic acid and ciprofloxacin
| Article | Year |
|---|---|
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Drug Design; Escherichia coli; Micrococcus luteus; Molecular Structure; Myristic Acid; Quantitative Structure-Activity Relationship; Staphylococcus aureus | 2006 |
Monocytes treated with ciprofloxacin and oxyLDL express myristate, priming atherosclerosis.
Topics: Atherosclerosis; Ciprofloxacin; Gene Expression Regulation; Humans; Lipoproteins, LDL; Monocytes; Myristic Acid; THP-1 Cells | 2020 |